THE IMPORTANCE OF ASSESSING VOLUMETRIC STATUS IN THE ACUTE DECOMPENSATION PHASE OF CHRONIC HEART FAILURE
DOI:
https://doi.org/10.55640/Keywords:
acute decompensated heart failure, volumetric status, congestion, lung ultrasound, inferior vena cava, diuretic therapy.Abstract
Acute decompensated heart failure (ADHF) is a life-threatening condition primarily characterized by fluid overload and systemic congestion. Accurate assessment of volumetric status is critical for guiding diuretic therapy and preventing both under-diuresis and worsening renal function. This article presents a clinical study conducted at the Department of Faculty Therapy of Andijan State Medical Institute. Using the IMRAD framework, the research evaluates the utility of integrating multi-parametric ultrasound assessment (inferior vena cava diameter and lung ultrasound) alongside standard clinical examination to determine the optimal decongestion strategy. The study involved 48 patients admitted with ADHF. The participants were divided into a standard care group and an ultrasound-guided management group. The results demonstrate that the ultrasound-guided approach led to a more significant reduction in NT-proBNP levels and a shorter duration of hospitalization compared to clinical assessment alone. The study concludes that objective instrumental monitoring of volume status is superior to physical examination for managing acute decompensation events.
Downloads
References
1.Ponikowski, P., Voors, A. A., Anker, S. D., et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 37(27), 2129-2200.
2.Mullens, W., Damman, K., Harjola, V. P., et al. (2019). The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 21(2), 137-155.
3.Gargani, L. (2011). Lung ultrasound: a new tool for the cardiologist. Cardiovascular Ultrasound, 9, 6.
4.Pellicori, P., et al. (2013). Ultrasound imaging of congestion in heart failure. Heart Failure Reviews, 18, 715-725.
5.Felker, G. M., et al. (2011). Diuretic strategies in patients with acute decompensated heart failure. New England Journal of Medicine, 364(9), 797-805.
6.Harjola, V. P., et al. (2017). Congestion in acute heart failure: a novel approach to assessment and treatment. European Journal of Heart Failure, 19(S1), 1-13.
7.Mentz, R. J., & O'Connor, C. M. (2016). Pathophysiology and clinical evaluation of acute heart failure. Nature Reviews Cardiology, 13(1), 28-35.
8.Tashtemirova, I. M. (2024). ON THE STATE OF FUNCTIONAL ACTIVITY OF THE SYMPATHETIC-ADRENAL SYSTEM AND FREE RADICAL PROCESSES IN WOMEN OF FERTILE AGE WITH METABOLIC SYNDROME.
9.Juraboyev, X. O., & Tashtemirova, I. M. (2025). ASSESSMENT OF LIPID PEROXIDATION PROCESSES AND LIPID METABOLISM DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE UNDERGOING COMBINED HYPOLIPIDEMIC THERAPY. INTERNATIONAL JOURNAL OF SOCIAL SCIENCE & INTERDISCIPLINARY RESEARCH ISSN: 2277-3630 Impact factor: 8.036, 14(07), 20-23.
10.Tashtemirova, I. M. (2025). DIAGNOSTIC CRITERIA AND ATTENTIVE REVIEWS IN THE TREATMENT OF CARDIAC X SYNDROME ANICIZED PATIENTS. INTERNATIONAL JOURNAL OF SOCIAL SCIENCE & INTERDISCIPLINARY RESEARCH ISSN: 2277-3630 Impact factor: 8.036, 14(07), 29-32.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
